Literature DB >> 17673518

Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.

Hong Y Zhou1, Yuen L Pon, Alice S T Wong.   

Abstract

Ovarian cancer is the primary cause of death from gynecological malignancies with a poor prognosis characterized by widespread peritoneal dissemination. However, mechanisms of invasion and metastasis in ovarian cancer remain poorly understood. Epidermal growth factor (EGF) and hepatocyte growth factor (HGF) are often both overexpressed and contribute to the growth of ovarian cancer by activating autocrine pathways. In the present study, we investigated the mechanisms of invasive activity of EGF, HGF, and their synergistic effects in human ovarian cancer cells. Here our data suggest that EGF and HGF may use unique and overlapping signaling cascades leading to the invasive phenotype. We revealed that HGF-mediated cell migration and invasion required the coordinate activation of the phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2. Although EGF-dependent invasive phenotype appeared to have similar requirements for phosphatidylinositol 3-kinase, this growth factor used the alternative p38 MAPK pathway for cell invasion. A significant role of p38 MAPK was further supported by the observation that expression of dominant negative p38 MAPK likewise inhibited EGF-dependent invasiveness and cell motility. We also showed that EGF cooperated with HGF to promote a highly invasive phenotype via the increased secretion of matrix metalloproteinase (MMP)-9. The coincident induction of MMP-9 was functionally significant because inclusion of MMP-9 inhibitor or an anti-MMP-9 neutralizing antibody abolished EGF- and HGF-induced cellular invasion. These findings provide insights into the mechanism of the malignant progression of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673518     DOI: 10.1210/en.2007-0361

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.

Authors:  Michelle K Y Siu; Hoi Yan Chan; Daniel S H Kong; Esther S Y Wong; Oscar G W Wong; Hextan Y S Ngan; Kar Fai Tam; Hongquan Zhang; Zhilun Li; Queeny K Y Chan; Sai Wah Tsao; Staffan Strömblad; Annie N Y Cheung
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-06       Impact factor: 11.205

2.  Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma.

Authors:  Kiran Kumar Velpula; Venkata Ramesh Dasari; Andrew J Tsung; Dzung H Dinh; Jasti S Rao
Journal:  Stem Cells Dev       Date:  2011-11-21       Impact factor: 3.272

3.  PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Invest Dermatol       Date:  2010-04-29       Impact factor: 8.551

4.  Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells.

Authors:  Jung-Chien Cheng; Christian Klausen; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2010-07-07

5.  Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model.

Authors:  Thilo S Lange; Yongping Zou; Rakesh K Singh; Kyu K Kim; Katrin Kristjansdottir; Giselle L S Sholler; Laurent Brard
Journal:  Chem Biol Drug Des       Date:  2010-05-11       Impact factor: 2.817

Review 6.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

Review 7.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

8.  Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation.

Authors:  Deeba N Syed; Farrukh Afaq; Sami Sarfaraz; Naghma Khan; Rajendra Kedlaya; Vijayasaradhi Setaluri; Hasan Mukhtar
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-09       Impact factor: 4.219

9.  Targeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activity.

Authors:  Aaron P Petty; Stephen E Wright; Kathleen A Rewers-Felkins; Michelle A Yenderrozos; Beth A Vorderstrasse; J Suzanne Lindsey
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

10.  Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model.

Authors:  Thilo S Lange; Ashley R Stuckey; Katina Robison; Kyu Kwang Kim; Rakesh K Singh; Christina A Raker; Laurent Brard
Journal:  Invest New Drugs       Date:  2009-07-07       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.